Form 4 for CRMD CorMedix Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001213900-25-001356 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-06 | 2025-01-02 | CRMD | David Matthew T | CFO | A - Grant | $0.00 | +62.5K | 110.4K | +130% | $0 | |
| 2025-01-06 | 2025-01-02 | CRMD | David Matthew T | CFO | F - Tax | $8.22 | -8,648 | 101.8K | -8% | -$71.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | A | A | 62,500 | $0.00 | 110,434 | D | — | — | (F1) These shares represent restricted stock units granted on 01/02/2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. |
| 2 | Common | Common Stock | 2025-01-02 | F | D | 8,648 | $8.22 | 101,786 | D | — | — |